Literature DB >> 28644915

Mechanistic Insights on the Reduction of CO2 to Silylformates Catalyzed by Ir-NSiN Species.

Alejandro Julián1, Jefferson Guzmán1, E A Jaseer2, Francisco J Fernández-Alvarez1, Raquel Royo3, Víctor Polo3, Pilar García-Orduña1, Fernando J Lahoz1, Luis A Oro1,2.   

Abstract

The hydrosilylation of CO2 with different silanes such as HSiEt3 , HSiMe2 Ph, HSiMePh2 , HSiMe(OSiMe3 )2 , and HSi(OSiMe3 )3 in the presence of catalytic ammounts of the iridium(III) complex [Ir(H)(CF3 CO2 )(NSiN*)(coe)] (1; NSiN*=fac-bis-(4-methylpyridine-2-yloxy); coe=cis-cyclooctene) has been comparatively studied. The activity of the hydrosilylation catalytic system based on 1 depends on the nature of the reducing agent, where HSiMe(OSiMe3 )2 has proven to be the most active. The aforementioned reactions were found to be highly selective toward the formation of the corresponding silylformate. It has been found that using 1 as catalyst precursor above 328 K decreases the activity through a thermally competitive mechanistic pathway. Indeed, the reduction of the ancillary trifluoroacetate ligand to give the corresponding silylether CF3 CH2 OSiR3 has been observed. Moreover, mechanistic studies for the 1-catalyzed CO2 -hydrosilylation reaction based on experimental and theoretical studies suggest that 1 prefers an inner-sphere mechanism for the CO2 reduction, whereas the closely related [Ir(H)(CF3 SO3 )(NSiN)(coe)] catalyst, bearing a triflate instead of trifluoroacetate ligand, follows an outer-sphere mechanism.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  N-Si-N ligands; carbon dioxide reduction; homogeneous catalysis; hydrosilylation; iridium

Year:  2017        PMID: 28644915     DOI: 10.1002/chem.201702246

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  1 in total

1.  Unprecedent formation of methylsilylcarbonates from iridium-catalyzed reduction of CO2 with hydrosilanes.

Authors:  Jefferson Guzmán; Pilar García-Orduña; Fernando J Lahoz; Francisco J Fernández-Alvarez
Journal:  RSC Adv       Date:  2020-03-05       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.